ArticleJournal of gynecologic oncology2024

Cost-effectiveness of atezolizumab plus chemotherapy for advanced/recurrent endometrial cancer.

Gengwei Huo et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.